Who is a candidate for regenerative therapy? It’s the right question to ask before pursuing any treatment — and the honest answer is that not everyone qualifies. PRP and stem cell therapy produce strong results for specific conditions and specific patients. For others, a different approach is more appropriate. Understanding the criteria helps you evaluate whether these treatments make clinical sense for your situation before investing time and money.

This article covers the general criteria for candidacy, which conditions respond best, which factors disqualify patients or require special evaluation, and how the assessment process works at our practice.

The Core Candidacy Question: Is There Viable Tissue to Repair?

Regenerative medicine works by amplifying your body’s own repair capacity. PRP delivers growth factors that stimulate existing cells to regenerate. Stem cells differentiate into new tissue and release signaling molecules that promote healing. Both approaches require viable tissue at the treatment site — enough living cells and biological infrastructure for the treatment to activate.

This is the most important principle in candidacy assessment. A patient with moderate knee arthritis has damaged cartilage, but that cartilage still has living cells that can respond to PRP or stem cell signals. A patient with end-stage bone-on-bone arthritis where cartilage has been completely destroyed has lost the biological substrate these treatments need. Regenerative therapy can still reduce inflammation and pain in that scenario, but structural cartilage restoration becomes unlikely.

The earlier in the disease or injury process you pursue regenerative treatment, the more the therapy has to work with — and the stronger the outcomes tend to be.

Conditions That Respond Well to Regenerative Therapy

Musculoskeletal Injuries and Chronic Pain

This is the primary domain of regenerative medicine in clinical practice. Conditions with strong evidence for PRP and stem cell therapy include:

• Joint arthritis — knee, shoulder, hip, and ankle, from mild to moderate severity
• Tendinopathy — rotator cuff, Achilles, patellar, lateral and medial epicondyle, plantar fascia
• Partial ligament and tendon tears — where the structure is damaged but not completely severed
• Spinal conditions — degenerative disc disease, facet joint arthropathy, sacroiliac joint dysfunction
• Chronic back and neck pain from disc degeneration or ligament laxity
• Post-surgical pain — residual pain after spine surgery, knee arthroscopy, or rotator cuff repair
• Neuropathy — peripheral nerve pain that hasn’t responded to medication

Patients Who Have Exhausted Conservative Options

A strong candidate profile includes patients who have tried physical therapy, anti-inflammatories, and cortisone injections without lasting relief. These patients have already confirmed that the injury isn’t going to resolve on its own and that symptom management alone isn’t sufficient. Regenerative therapy addresses the tissue-level problem those approaches leave untouched.

Patients Seeking to Avoid Surgery

Many patients are told surgery is their only remaining option — often before regenerative alternatives have been properly explored. For candidates with intact-enough tissue and appropriate pathology, PRP therapy or stem cell injections can meaningfully delay or eliminate the need for surgical intervention. This is particularly relevant for knee replacement candidates with moderate arthritis and patients facing spinal fusion for disc disease.

Athletes with Overuse and Sports Injuries

Active patients with tendon injuries, partial tears, and repetitive stress conditions are among the best candidates for regenerative therapy. Their tissue is generally healthier than in older or sedentary patients, their healing capacity is stronger, and the goal — returning to sport — is clear and measurable. PRP consistently outperforms cortisone for sports-related tendinopathy in long-term outcome studies.

Factors That Affect Candidacy

Age

Age alone doesn’t disqualify anyone. Patients in their 70s and 80s receive PRP and stem cell therapy with positive outcomes. What matters more than age is biological function — platelet quality for PRP, stem cell count and viability for stem cell therapy. Adipose-derived stem cells maintain higher concentrations than bone marrow stem cells as patients age, which is one reason adipose is often preferred for older patients.

Severity of Damage

Mild to moderate damage produces the best outcomes. Severe structural damage — Grade IV cartilage loss (bone-on-bone), complete tendon rupture, advanced spinal instability — is harder to address regeneratively. That doesn’t mean regenerative therapy has nothing to offer in severe cases, but expectations need to be calibrated: pain reduction is achievable, structural restoration is less likely.

Overall Health and Medications

Several health factors affect the quality of biological material used in treatment. Platelet function is reduced by aspirin, NSAIDs, and certain anticoagulants — these typically need to be paused before PRP. Smoking significantly impairs healing capacity and reduces treatment effectiveness. Uncontrolled diabetes slows tissue repair and affects outcome. Active infection at or near the injection site is an absolute contraindication. Immunosuppressive therapy can affect how the body responds to regenerative signals.

Platelet Count and Blood Health

PRP depends on your platelets. Patients with low platelet counts (thrombocytopenia) or platelet dysfunction disorders may not produce PRP concentrated enough to be therapeutically effective. A basic blood panel before treatment confirms whether PRP is viable. Most patients have no issues here, but it’s worth verifying.

Cancer History

Active cancer is a contraindication for both PRP and stem cell therapy — growth factor delivery and cell proliferation signals are not appropriate when malignant cells are present. Patients with a history of cancer who are in confirmed remission require evaluation on a case-by-case basis. This is a nuanced area where the specific cancer type, remission status, and treatment history all matter.

Who Is Not a Good Candidate

Regenerative therapy is not appropriate for every patient. Clear disqualifiers include active infection, active cancer, certain blood disorders affecting platelet function, and pregnancy. Relative contraindications — factors that require careful evaluation rather than automatic exclusion — include severe structural damage with minimal remaining viable tissue, poorly controlled systemic disease, and current immunosuppressive therapy.

There are also conditions where surgery is genuinely the right answer first. Complete rotator cuff tears that have fully retracted need surgical repair — PRP can support healing after surgery, but it can’t reattach a fully torn tendon. Severe spinal instability with neurological compromise may require structural stabilization before regenerative treatment is appropriate.

A provider who tells every patient they’re a candidate for regenerative therapy without a thorough clinical evaluation is not doing medicine — they’re doing sales. The evaluation process exists to protect you from pursuing treatment that won’t work for your specific condition.

How Candidacy Is Evaluated at Our Practice

At Regenerative Sport, Spine & Spa in Lake Nona, Orlando, every patient evaluation starts with a review of current imaging — MRI is the most informative for soft tissue and cartilage assessment — alongside a detailed history of symptoms, prior treatments, and response to those treatments.

Dr. Manuel Colón and Dr. Dana Kleinman perform a physical examination and assess each patient’s specific pathology before making any treatment recommendation. If regenerative therapy is appropriate, we explain which treatment, how many sessions, and what realistic outcomes look like for your condition. If it’s not appropriate — or if surgery should come first — we tell you that directly.

The goal is the right treatment for the right patient, not a default recommendation. Contact our team at 888-557-5682 to schedule your evaluation at 10920 Moss Park Rd Suite 218, Orlando, FL 32832.

To understand specific treatments in more depth before your consultation, read about PRP vs stem cells, how many sessions are typically needed, and the FDA regulatory framework for regenerative medicine.

Frequently Asked Questions

Am I a candidate for regenerative therapy?

You’re likely a candidate if you have a musculoskeletal condition — joint arthritis, tendinopathy, disc degeneration, ligament injury, or chronic pain — that hasn’t fully resolved with physical therapy, anti-inflammatories, or cortisone injections, and you’re not currently dealing with active cancer, active infection, or a platelet function disorder. The only accurate way to confirm candidacy is a clinical evaluation with current imaging. General profiles that consistently qualify include mild-to-moderate arthritis, partial tendon tears, degenerative disc disease, and post-surgical pain.

Does age affect whether I qualify for PRP or stem cell therapy?

Age alone doesn’t disqualify you. Patients in their 70s and 80s respond well to both PRP and stem cell therapy. What matters more is biological function — platelet quality for PRP and stem cell viability for stem cell therapy. Adipose-derived stem cells maintain higher concentrations as patients age compared to bone marrow-derived cells, making adipose the preferred source for many older patients. Severity of damage matters more than age in determining realistic outcomes.

Can I get regenerative therapy if I’ve already had surgery?

Yes. Post-surgical pain is a well-established indication for both PRP and stem cell therapy. Patients with residual pain after spine surgery, knee arthroscopy, or rotator cuff repair — where the surgery didn’t fully resolve the symptoms — often respond well to regenerative treatment for the remaining tissue damage. PRP is also used during and after surgery to accelerate healing at the repair site. Prior surgery doesn’t disqualify you; it’s one data point in the full clinical picture.

What conditions disqualify someone from regenerative therapy?

Absolute contraindications include active cancer, active infection at or near the injection site, and certain blood disorders affecting platelet function. Pregnancy is also a contraindication. Relative contraindications — factors requiring careful case-by-case evaluation — include severe structural damage with minimal remaining viable tissue, poorly controlled systemic disease, and current immunosuppressive therapy. Cancer history in confirmed remission is evaluated individually based on cancer type and treatment history.

How do I know if my condition is too severe for regenerative therapy to help?

Current imaging — specifically MRI — is the primary tool for assessing severity. End-stage bone-on-bone arthritis with complete cartilage loss is the clearest example of a condition where structural repair is unlikely, though pain reduction may still be achievable. Complete tendon ruptures with full retraction typically need surgical repair before regenerative therapy is appropriate. For most conditions that fall short of those extremes, there’s meaningful clinical benefit to explore. A provider who reviews your imaging and gives you a direct assessment of what’s realistic is the right starting point.